Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Classement en actions #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Prix de l'action
$240.45
Capitalisation boursière
$579.46B
Changement (1 jour)
0.51%
Changement (1 an)
46.88%
Pays
US
Échange Johnson & Johnson (JNJ)

Catégorie

Revenus pour Johnson & Johnson (JNJ)
Revenus en Dec 2025 TTM : $94.19B
Selon les derniers rapports financiers de Johnson & Johnson, le chiffre d'affaires actuel de l'entreprise (TTM) est de $94.19B. En 2024, l'entreprise a réalisé un chiffre d'affaires de $88.82B une augmentation par rapport à le chiffre d'affaires de l'année 2023, qui était de $85.16B. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Johnson & Johnson de 2000 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $94.19B 0.00%
2025 $94.19B 6.05%
2024 $88.82B 4.30%
2023 $85.16B 8.15%
2022 $78.74B -4.65%
2021 $82.58B 0.64%
2019 $82.06B 0.59%
2018 $81.58B 6.71%
2017 $76.45B 6.34%
2016 $71.89B 2.59%
2015 $70.07B -5.73%
2014 $74.33B 4.23%
2013 $71.31B 6.08%
2012 $67.22B 3.37%
2011 $65.03B 5.59%
2010 $61.59B -0.50%
2009 $61.90B -2.90%
2008 $63.75B 4.34%
2007 $61.10B 14.57%
2006 $53.32B 5.56%
2005 $50.51B 6.69%
2004 $47.35B 13.10%
2003 $41.86B 15.33%
2002 $36.30B 12.32%
2001 $32.32B 10.78%
2000 $29.17B 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
$65.18B -30.80%
US
$61.16B -35.07%
US
$56.15B -40.39%
CH
$58.74B -37.64%
GB
$65.01B -30.98%
US